Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Dow Jones At Record High As It Sits Between FDA Pfizer And Moderna Vaccine Decisio

Published 15/12/2020, 05:46

With the FDA approving the emergency use of the Pfizer/BioNTech vaccine on Saturday, ahead of their meeting to discuss the Moderna (NASDAQ:MRNA) preparation on Thursday, the Dow Jones returned to record high territory.

Climbing 220 points, the Dow struck 30,270 – close at that level and the index has itself a fresh all-time high.

Between now and Thursday’s FDA meeting – the next flagship event for the Dow – lies a Chinese data dump on Tuesday, the flash PMIs for December on Wednesday afternoon, and the final Federal Reserve meeting of the year on Wednesday evening, one that will likely see a further insistence from Jerome Powell and co. about the need for substantial fiscal stimulus.

Though it lost a step as the day went on – perhaps disappointed that the chances of a no deal Brexit have only fallen from ‘very, very likely’ to ‘possible’ following a reported concession from Boris Johnson – the pound nevertheless benefited from a sense of relief on Monday.

Against the dollar, it was up 0.7%, just over half its initial growth this morning, while against the euro it rose 0.6%.

Despite sterling’s slowing gains, the FTSE couldn’t join its US and Eurozone peers significantly in the green. The blue-chip index had to make do with a 0.1% increase, compared to the 1.1% surge seen by the FTSE 250.

"Disclaimer: Spreadex provides an execution only service and the comments above do not constitute (or should not be construed as constituting) investment advice or recommendations, or a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any person placing trades based on their interpretations of the above comments does so entirely at their own risk. Spreadex Ltd is a financial and sports spread betting and sports fixed odds betting firm, which specialises in the personal service and credit area. Founded in 1999, Spreadex is recognised as one of the longest established spread betting firms in the industry with a strong reputation for its high level of customer service and account management.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In relation to spread betting, Spreadex Ltd is authorised and regulated by the Financial Conduct Authority. Spread betting carries a high level of risk to your capital and can result in losses larger than your initial stake/deposit. It may not be suitable for everyone, so please ensure you fully understand the risks involved."

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.